Immune Response
Patent approval, 2017, All patent inquiries should be directed to James Passé at Passé Intellectual Properties, LLC. 919-356-8199 or 1717 Brassfield Rd, Raleigh, NC 27614
Gut Health
Seeking Balance  —  our inner economy is reliant on a variety of microbiota. The importance of which is well understood at BioAvivus. Of course, each microbe does its respective job admirably, though some may run rampant (when conditions are favorable), growing in number to such a degree as to destabilize the efficacy of the biosystem. We call this imbalance dysbiosis. Working correctly, these microorganisms will be in a state of symbiosis. When you feel out-of-sync or ill-at-ease, this dis-ease is your warning of impending illness and must be addressed before becoming untenable and possibly requiring hospitalization. Our highly qualified team is working on solutions that do not upset this vital balance. Keeping in mind that, frequently, less is more.
We are a biotech company focused on nanofication and repurposing of existing, tested and approved chemical compounds.


Charles W. Vaughn, President/CEO, former C-Level Executive, Pfizer, Novariti Fellow, American Society of Angiology.


Richard K. Bogan, M.D., Exec. Sr. Vice-President and Chief Medical Officer, Fellow of The American Academy of Sleep, Board Certified Pulmonology.


Peter Kowey, M.D., Cardiology, Electrophysiology, Jefferson Medical College, Thomas Jefferson University.


Harry D. Oberkefell, former President Parke-Davis.


Michael E. George, former President DuPont-Merck.


Barry Buzogany, Esq., former C-Level Pharmaceuticals and Bio-Tech.


Dr. David J. Durgan, Assistant Professor, Anesthesiology, Baylor College of Medicine, Project Leader National Institute of Health, Human Microbiome Project.


Thank you for your interest in BioAvivus. Please use this form if you have any questions about what we do and we will get back to you very soon.